MLCL — Molecule Holdings Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesHighly SpeculativeMicro Cap
Annual cashflow statement for Molecule Holdings, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2018 October 31st | 2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.346 | -2.92 | -3.33 | -4.23 | -4.54 |
| Depreciation | |||||
| Non-Cash Items | 0.254 | 2.64 | 1.89 | 1.97 | 1.04 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.007 | 0.132 | 0.463 | -1.18 | 1.72 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -0.099 | -0.153 | -0.926 | -2.87 | -1.13 |
| Capital Expenditures | -0.178 | -0.042 | -1.9 | -0.077 | -0.033 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.009 | 0.094 | 0.633 | 0.244 | 0.003 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.17 | 0.051 | -1.27 | 0.167 | -0.03 |
| Financing Cash Flow Items | — | — | -0.159 | -0.369 | -0.498 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.108 | 0.095 | 0.806 | 3 | 0.039 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.161 | -0.007 | -1.39 | 0.301 | -1.12 |